Updates on gastric electrical stimulation to treat obesity: Systematic review and future perspectives

Table 2 Summary of TANTALUS^® trials

Ref.1	Sample size (n), enrolled/completed	Mean age (yr)	Mean weight, (kg)/mean BMI (kg/m2)	Follow-up (mo)	Lifestyle change (required/advice given)	Co-morbidities
Lebovitz et al[38], 2013	40/40	NR	110.5 ± 3.5/NR	NR	NR/NR	NR
Sanmiguel et al[70], 2009	14/11	42	107.3 ± 20.1/39 ± 1	6	N/Y	T2DM
Bohdjalian et al[39], 2009	24/21	50.0 ± 1.6	123.7 ± 4.5/41.9 ± 1.0	12	NR/NR	T2DM
Policker et al[37], 2009	50/50	NR	NR/NR	6+	NR/NR	T2DM
Bohdjalian et al[71], 2009	13/13	53.8 ± 2.6	104.4 ± 4.4/37.2 ± 1.1	3	N/Y	T2DM
Policker et al[69], 2008	12/12	50.8 ± 2.2	130 ± 6.5/NR	9	N/Y	T2DM
Sanmiguel et al[43], 2007	12/11	39.1 ± 8.9	NR/41.6 ± 3.4	1.5	N/NR	T2DM
Bohdjalian et al[72], 2006	12/9	36.1 ± 2.8	128.8 ± 5.2/43.2 ± 2.7	12	N/Y	HTN

¹All trials were open-label and none were randomized. T2DM: Type 2 diabetes.